Mettler-Toledo price target lowered to $1,250 from $1,500 at BofA

TipRanks

Tue, Apr 15, 2025, 7:02 AM 1 min read

BofA analyst Michael Ryskin lowered the firm’s price target on Mettler-Toledo (MTD) to $1,250 from $1,500 and keeps a Neutral rating on the shares. Sentiment for Life Sciences and Diagnostic Tools and Contract Research Organizations is “particularly negative” heading into earnings given that these companies “sit at the intersection of a number of policy changes from the Trump Administration,” including headwinds from NIH budget cuts and global tariffs, as well as broader macro concerns, especially around China, the analyst tells investors in a preview for the group.

• Discover outperforming stocks and invest smarter with Top Smart Score Stocks.

• Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on MTD:

Disclaimer & DisclosureReport an Issue

• Mettler-Toledo upgraded to Buy from Neutral at Citi

• Mettler-Toledo price target lowered to $1,400 from $1,450 at Citi